C

Clovis Oncology Inc
XETRA:C6O

Watchlist Manager
Clovis Oncology Inc
XETRA:C6O
Watchlist
Price: 8.7 EUR -10.66% Market Closed
Market Cap: 3B EUR

Intrinsic Value

C6O price has not been updated for more than 3 years. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of C6O.

The Intrinsic Value is calculated as the average of DCF and Relative values:

C6O Intrinsic Value
Not Available
C
Base Case Scenario
Compare C6O to

Fundamental Analysis

Clovis Oncology Inc
XETRA:C6O
US
Biotechnology
Market Cap
3B EUR
IPO
Nov 16, 2011
US
Biotechnology
Market Cap
3B EUR
IPO
Nov 16, 2011
Price
€
$
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about C6O?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clovis Oncology Inc

Current Assets 102.2m
Cash & Short-Term Investments 58.3m
Receivables 22.6m
Other Current Assets 21.3m
Non-Current Assets 244.6m
PP&E 21.5m
Intangibles 119.4m
Other Non-Current Assets 103.6m
Current Liabilities 747.9m
Accounts Payable 18.1m
Accrued Liabilities 68.8m
Other Current Liabilities 661m
Non-Current Liabilities 16.8m
Other Non-Current Liabilities 16.8m
Efficiency

Free Cash Flow Analysis
Clovis Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Clovis Oncology Inc

Revenue
133m USD
Cost of Revenue
-37m USD
Gross Profit
96.1m USD
Operating Expenses
-302.7m USD
Operating Income
-206.7m USD
Other Expenses
-45.2m USD
Net Income
-251.9m USD
Fundamental Scores

C6O Profitability Score
Profitability Due Diligence

Clovis Oncology Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
Exceptional Gross Margin
Strong 3Y Average Gross Margin
42/100
Profitability
Score

Clovis Oncology Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

C6O Solvency Score
Solvency Due Diligence

Clovis Oncology Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
25/100
Solvency
Score

Clovis Oncology Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

C6O Price Targets Summary
Clovis Oncology Inc

There are no price targets for C6O.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Clovis Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for C6O is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y